The actor waxes nostalgic about his travel adventures around the world while filming his new show, Breaking Bread.

To honor the indigenous foods of the world, take a cue from this American people and make an ancient bread that requires just ...

Shalhoub is part of a crowded field of celeb travel hosts, which includes Rainn Wilson, Eugene Levy, Stanley Tucci, Orlando Bloom, Zac Efron, José Andrés, Chris Hemsworth, Will Smith, Eva Longoria and ...

The launch of the “Brand Guyana Gondola” at Massy Mega, Turkeyen, on Saturday, September 20, a collaborative effort by the Guyana Office for Investment (GO-Invest), Guyana Marketing Corporation (GMC) ...

Tony Shalhoub is loath to compare his upcoming CNN series, "Breaking Bread," to the travel food shows hosted by his frequent collaborator Stanley Tucci, who directed him in the gourmand classic "Big ...

On the other side of the ocean, the most famous beer fest in the world is coming to a close. Over 200 years ago, a tradition ...

The river is older than our arguments. It arrives before parties and platforms, before precinct maps and press releases; it carries the seasons of a place in its skin. Look east and you will find the ...

https://siris-libraries.si.edu/ipac20/ipac.jsp?&profile=liball&source=~!silibraries&uri=full=3100001~!910958~!0#focus ...

Cassava Sciences (SAVA) has quickly become the subject of renewed attention after CEO Richard Barry put his own money on the line. Just weeks after halting the company’s long-running Alzheimer’s ...

Professional services firm Accenture and IT services and infrastructure company Cassava Technologies have formed a strategic partnership to enable Cassava’s customers to process AI workloads and data ...

Davidsbeenhere visits Daniel, the King of Cassava in Dominica's Kalinago Territory, for a delicious cassava pancake with coconut. Crispy, sweet, and savory! Elon Musk is telling his followers to ...

Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the clinical-stage biotech company said a trial of a treatment for mild to moderate ...